Effect of Endothelin Antagonism on Contractility, Intracellular Calcium Regulation and Calcium Regulatory Protein Expression in Right Ventricular Hypertrophy of the Rat

Basic and Clinical Pharmacology and Toxicology

Volumn 94, Issue 1, 2004, Pages 37-45

  Stessel, Heike ^a   Brunner, Friedrich ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

3 BENZYL 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 2 BUTENOIC ACID; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; MONOCROTALINE; PHOSPHOLAMBAN; REGULATOR PROTEIN; 1,3 DIOXOLANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DIASTOLE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEART AFTERLOAD; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; SARCOPLASMIC RETICULUM; ANIMAL; BLOOD PRESSURE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; HEART CONTRACTION; METABOLISM; ORGAN SIZE; SPRAGUE DAWLEY RAT;

ANIMALIA;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CALCIUM; DIOXOLES; ENDOTHELINS; FEMALE; HYPERTROPHY, RIGHT VENTRICULAR; MONOCROTALINE; MYOCARDIAL CONTRACTION; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SARCOPLASMIC RETICULUM;

EID: 1642316316     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2004.pto_940107.x     Document Type: Article

References (33)

1. Arai, M., T. Suzuki & R. Nagai: Sarcoplasmic reticulum genes are upregulated in mild cardiac hypertrophy but downregulated in severe cardiac hypertrophy induced by pressure overload. J. Mol. Cell. Cardiol. 1996, 28, 1583-1590.
2. Arai, M., A. Yoguchi, T. Iso, T. Takahashi, S. Imai, K. Murata & T. Suzuki: Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. Amer. J. Physiol. 1995, 37, H2084-H2091.
3. Balke, C. W. & S. R. Shorofsky: Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc. Res. 1998, 37, 290-299.
4. Brown, L. A., D. J. Nunez, C. I. O. Brookes & M. R. Wilkins: Selective increase in endothelin-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aorto-venacaval fistula rat. Cardiovasc. Res. 1995, 29, 768-774.
5. Brunner, F., G. Wölkart & S. Haleen: Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxyphenyl-)-4-oxobut-2-enoate-sodium (PD 155080). J. Pharmacol. Exp. Therap. 2002, 300, 442-449.
6. Chen, S.-J., Y.-F. Chen, Q. Meng, J. Durand, V. DiCarlo & S. Oparil: Endothelin receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J. Appl. Physiol. 1995, 79, 2122-2131.
7. Gout, B., M.-J. Quiniou, N. Khandoudi, C. Le Dantec & B. Saiag: Impaired endothelium-dependent relaxation of adrenomedullin in monocrotaline-treated rat arteries. Eur. J. Pharmacol. 1999, 380, 23-30.
8. Grossman, W. & W. H. Barry: Diastolic pressure-volume relations in the diseased heart. Fed. Proc. 1980, 39, 148-155.
9. Gwathmey, J., R. Liao & J. Ingwall: Comparison of twitch force and calcium handling in papillary muscles from right ventricular pressure overload hypertrophy in weanling and juvenile ferrets. Cardiovasc. Res. 1995, 29, 475-481.
10. Homcy, C.: Signaling hypertrophy: how many switches, how many wires. Circulation 1998, 97, 1890-1892.
11. Ichikawa, K.-I., C. Hidai, C. Okuda, S.-I. Kimata, R. Matsuoka, S. Hosoda, T. Quertermous & M. Kawana: Endogenous endothelin-1 mediates cardiac hypertrophy and switching of myosin heavy chain gene expression in rat ventricular myocardium. J. Amer. Coll. Cardiol. 1996, 27, 1286-1291.
12. Ito, H.: Endothelins and cardiac hypertrophy. Life Sci. 1997, 61, 585-593.
13. A receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 1994, 89, 2198-2203.
14. Kannel, W. B., W. P. Castelli, P. M. McNamara, P. A. McKee & M. Feinleib: Role of blood pressure in the development of congestive heart failure. The Framingham study. New Engl. J. Med 1972, 287, 781-787.
15. Kögler, H., O. Hartmann, K. Leineweber, P. Nguyen van, P. Schott, O.-E. Brodde & G. Hasenfuss: Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat. Circ. Res. 2003, 93, 230-237.
16. Korstjens, I. J. M., C. H. F. C. Rouws, W. J. Van der Laarse, L. Van der Zee & G. J. M. Stienen: Myocardial force development and structural changes associated with monocrotaline induced cardiac hypertrophy and heart failure. J. Muscle Res. Cell Motil. 2002, 23, 93-102.
17. Loennechen, J. P., V. Beisvag, I. Arbo, H. L. Waldum, A. K. Sandvik, S. Knardahl & Ø. Ellingsen: Chronic carbon monoxide exposure in vivo induces myocardial endothelin-1 expression and hypertrophy in rat. Pharmacology & Toxicology 1999, 85, 192-197.
18. Lompré, A.-M., M. Anger & D. Levitsky: Sarco(endo)plasmic reticulum calcium pumps in the cardiovascular system: function and gene expression. J. Mol. Cell. Cardiol. 1994, 26, 1109-1121.
19. A Receptor Blockade Trial (HEAT). Circulation 2002, 106, 2666-2672.
20. Meyrick, B., W. Gamble & L. Reid: Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Amer. J. Physiol. 1980, 239, H692-H702.
21. Miyauchi, T., R. Yorikane, S. Sakai, T. Sakurai, M. Okada, M. Nishikibe, M. Yano, I. Yamaguchi, Y. Sugishita & K. Goto: Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ. Res. 1993, 73, 887-897.
22. 2+-ATPase during progression of left ventricular hypertrophy. Amer. J. Physiol. 1997, 272, H2416-H2424.
23. 2+ uptake. Circulation 2000, 102, 1582-1588.
24. Rubin, L. J. & S. Roux: Bosentan: a dual endothelin receptor antagonist. Expert Opin. Invest. Drugs 2002, 11, 991-1002.
25. 2+ regulation and nitric oxide mediated coronary relaxation. Cardiovasc. Res. 2000, 48, 332-345.
26. Simmerman, H. K. B. & L. R. Jones: Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol. Rev. 1998, 78, 921-947.
27. A receptor antagonist. Pulmon. Pharmacol. Therap. 2000, 13, 87-97.
28. Ueno, M., T. Miyauchi, S. Sakai, R. Yamauchi-Kohno, K. Goto & I. Yamaguchi: A combination of oral endothelin-A receptor antagonist and oral prostacyclin analogue is superior to each drug alone in ameliorating pulmonary hypertension in rats. J. Amer. Coll. Cardiol. 2002, 40, 175-181.
29. 2+ ATPase promoter activity during endothelin-1 induced hypertrophy of cultured rat cardiomyocytes. Cardiovasc. Res. 1998, 37, 503-514.
30. Willette, R. N., K. M. Anderson, A. H. Nelson, A. R. Olzinski, T. Woods, R. W. Coatney, N. Aiyar, E. H. Ohlstein & F. C. Barone: Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction. J. Cardiovasc. Pharmacol. 2001, 38, 606-617.
31. Woessner, J. F. J.: The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 1961, 93, 440-447.
32. Wölkart, G., H. Strömer & F. Brunner: Calcium handling and role of endothelin-1 in monocrotaline right ventricular hypertrophy of the rat. J. Mol. Cell. Cardiol. 2000, 32, 1995-2005.
33. Yamazaki, T., I. Komuro, S. Kudoh, Y. Zou, I. Shiojima, Y. Hiroi, T. Mizuno, K. Maemura, H. Kurihara, R. Aikawa, H. Takano & Y. Yazaki: Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J. Biol. Chem. 1996, 271, 3221-3228.